Products Affected - Description
Zonatuss capsule, Vertical
150 mg, 100 count (NDC 68025-0058-10) - discontinued
Reason for the Shortage
- Amneal and Ascend Laboratories cannot provide a reason for the shortage.
- Caraco discontinued benzonatate capsules in mid-2015.
- Zydus states the reason for the shortage was manufacturing delay.
- Pfizer had Tessalon Perles on shortage due to supply and demand issues.
- Vertical discontinued Zonatuss in 2016.
Tessalon Perles capsule, Pfizer
100 mg, 100 count (NDC 00069-0122-01)
Benzonatate capsule, Amneal
100 mg, 100 count (NDC 65162-0536-10)
100 mg, 500 count (NDC 65162-0536-20)
200 mg, 100 count (NDC 65162-0537-10)
200 mg, 500 count (NDC 65162-0537-20)
Benzonatate capsule, Ascend
100 mg, 100 count (NDC 67877-0105-01)
100 mg, 500 count (NDC 67877-0105-05)
200 mg, 100 count (NDC 67877-0106-01
200 mg, 500 count (NDC 67877-0106-05)
Benzonatate capsule, Bionpharma
100 mg, 100 count (NDC 69387-0119-01)
100 mg, 500 count (NDC 69387-0119-05)
200 mg, 100 count (NDC 69387-0120-01)
200 mg, 500 count (NDC 69387-0120-05)
Benzonatate capsule, Major
100 mg, 100 count (NDC 00904-5904-60)
Benzonatate oral capsule, Tagi Pharma
200 mg, 100 count (NDC 51224-0001-50)
Benzonatate capsule, Zydus
100 mg, 100 count (NDC 68382-0247-01)
Estimated Resupply Dates
All marketed presentations are available.
May 9, April 28 and 13, March 10 and 2, February 5, 2016; December 28, 22 and 16, September 18, August 24, July 17 and 1, June 22 and 2, May 26 and 6, April 22, 20 and 2, March 23 and 4, January 21, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins